[50] Ucar BI, Erikci A,

Kosemehmetoglu K, Ozkul C, Iskit AB, Ucar G, Zeren S. Effects of endothelin receptor blockade and COX inhibition on intestinal I/R injury in a rat model: Experimental research. International Journal of Surgery. 2020 Nov 1;83:89-97.

[51] Farhadi A, Banan AL, Fields J, Keshavarzian AL. Intestinal barrier: an interface between health and disease. Journal of gastroenterology and hepatology. 2003 May;18(5):479-97.

[52] Chang M, Alsaigh T, Kistler EB, Schmid-Schönbein GW. Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PloS one. 2012 Jun 29;7(6):e40087.

[53] Wolochow H, Hildebrand GJ, Lamanna C. Translocation of Microorganisms across the Intestinal Wall of the Rat: Effect of Microbial Size and Concentration [with Discussion]. The Journal of infectious diseases. 1966 Oct 1;116(4):523-8.

[54] Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infection and immunity. 1979 Feb;23(2):403-11.

[55] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016 Feb 23;315(8):801-10.

[56] Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Critical care medicine. 1999 Jul 1;27(7):1230-51.

[57] Diamond CE, Khameneh HJ, Brough D, Mortellaro A. Novel Perspectives on Non-Canonical Inflammasome Activation. ImmunoTargets and therapy. 2015 Jul 24;4:131-41.

[58] Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell. 2011 Nov 11;147(4):868-80.

[59] Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, Bauer M, Riedemann NC. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Critical care. 2011 Aug;15(4):1-8.

[60] van Vught LA, Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J, Schultz MJ, Nürnberg P, Bonten MJ, Cremer OL, van der Poll T. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. Jama. 2016 Apr 12;315(14):1469-79.

[61] Wosen JE, Mukhopadhyay D, Macaubas C, Mellins ED. Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts. Frontiers in immunology. 2018 Sep 25;9:2144.

[62] Schmid-Schönbein GW, Hugli TE. A new hypothesis for microvascular inflammation in shock and multiorgan failure: self-digestion by pancreatic enzymes. Microcirculation. 2005 Jan 1;12(1):71-82.

[63] Peoc'h K, Nuzzo A, Guedj K, Paugam C, Corcos O. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. Clinical Chemistry and Laboratory Medicine (CCLM). 2018 Mar 1;56(3):373-85.

*Intestinal Barrier Dysfunction, Bacterial Translocation and Inflammation: Deathly Triad… DOI: http://dx.doi.org/10.5772/intechopen.99554*

[64] Altshuler AE, Kistler EB, Schmid-Schönbein GW. Autodigestion: proteolytic degradation and multiple organ failure in shock. Shock (Augusta, Ga.). 2016 May;45(5):483.

[65] DeLano FA, Hoyt DB, Schmid-Schönbein GW. Pancreatic digestive enzyme blockade in the intestine increases survival after experimental shock. Science translational medicine. 2013 Jan 23;5(169):169ra11-.

[66] Williams JM, Duckworth CA, Burkitt MD, Watson AJ, Campbell BJ, Pritchard DM. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Veterinary pathology. 2015 May;52(3):445-55.

[67] Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings?. Surgery. 2002 Mar 1;131(3):241-4.

[68] Morelli A, Passariello M. Hemodynamic coherence in sepsis. Best Practice and Research Clinical Anaesthesiology. 2016 Dec 1;30(4):453-63.

[69] Kumar V. Inflammasomes: Pandora's box for sepsis. Journal of inflammation research. 2018;11:477.

[70] Thorburn T, Aali M, Lehmann C. Immune response to systemic inflammation in the intestinal microcirculation. Front. Biosci. (Landmark Ed). 2018 Jan 1;23:782-95.

[71] Boisrame-Helms J, Kremer H, Schini-Kerth V, Meziani F. Endothelial dysfunction in sepsis. Current Vascular Pharmacology. 2013 Mar 1;11(2):150-60.

[72] Wang L, Bastarache JA, Ware LB. The coagulation cascade in sepsis. Current pharmaceutical design. 2008 Jul 1;14(19):1860-9.

[73] Nakamura S, Imamura T, Okamoto K. Tissue factor in neutrophils: yes. J Thromb Haemost. 2004;2(2): 214-7.

[74] Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation. Journal of intensive care. 2016 Dec;4(1):1-8.

[75] Barrett CD, Moore HB, Banerjee A, Silliman CC, Moore EE, Yaffe MB. Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin. The journal of trauma and acute care surgery. 2017 Dec;83(6):1053.

[76] Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nature medicine. 2010 Aug;16(8):887-96.

[77] Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. science. 2004 Mar 5;303(5663):1532-5.

[78] Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arteriosclerosis, thrombosis, and vascular biology. 2012 Aug;32(8):1777-83.

[79] von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, Byrne RA. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. Journal of Experimental Medicine. 2012 Apr 9;209(4):819-35.

[80] Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proceedings of the National Academy of Sciences. 2010 Sep 7;107(36):15880-5.

[81] Samuels JM, Moore HB, Moore EE. Coagulopathy in severe sepsis: interconnectivity of coagulation and the immune system. Surgical infections. 2018 Feb 1;19(2):208-15.

[82] Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Diagnosis and management of sepsisinduced coagulopathy and disseminated intravascular coagulation. Journal of thrombosis and haemostasis: JTH. 2019 Nov;17(11):1989-94.

[83] Kurosawa S, Stearns-Kurosawa DJ. Complement, thrombotic microangiopathy and disseminated intravascular coagulation. Journal of intensive care. 2014 Dec;2(1):1-8.

[84] Hamad OA, Bäck J, Nilsson PH, Nilsson B, Ekdahl KN. Platelets, complement, and contact activation: partners in inflammation and thrombosis. Current Topics in Innate Immunity II. 2012:185-205.

[85] Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F. Generation of C5a in the absence of C3: a new complement activation pathway. Nature medicine. 2006 Jun;12(6):682-7.

[86] Magnotti LJ, Upperman JS, Xu DZ, Lu Q, Deitch EA. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Annals of surgery. 1998 Oct;228(4):518.

[87] Fu WL, Xiao GX, Yue XL, Hua C, Lei MP. Tracing method study of bacterial translocation in vivo. World

journal of gastroenterology. 2000 Feb 15;6(1):153.

[88] Yokoyama Y, Fukaya M, Mizuno T, Ebata T, Asahara T, Nagino M. Clinical importance of "occult-bacterial translocation" in patients undergoing highly invasive gastrointestinal surgery: A review. Surgery Today. 2020 Aug 28:1-8.

[89] Vaishnavi C, Kochhar R, Kaur S, Singh G. Estimation of endotoxin in infected bile from patients with biliary diseases. Tropical gastroenterology: official journal of the Digestive Diseases Foundation. 2006 Jan 1;27(1):22-5.

[90] Su W, Ding X. Methods of endotoxin detection. Journal of laboratory automation. 2015 Aug;20(4):354-64.

[91] Galipeau HJ, Verdu EF. The complex task of measuring intestinal permeability in basic and clinical science. Neurogastroenterology and Motility. 2016 Jul;28(7):957-65.

[92] Camilleri Á, Madsen K, Spiller R, Van Meerveld BG, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterology and Motility. 2012 Jun;24(6):503-12.

[93] Farré R, Vicario M. Abnormal barrier function in gastrointestinal disorders. Gastrointestinal Pharmacology. 2016:193-217.

[94] Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal immunology. 2010 May;3(3):247-59.

[95] Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World Journal of Gastrointestinal Surgery. 2010 Mar 27;2(3):61.

*Intestinal Barrier Dysfunction, Bacterial Translocation and Inflammation: Deathly Triad… DOI: http://dx.doi.org/10.5772/intechopen.99554*

[96] Stappaerts J, Brouwers J, Annaert P, Augustijns P. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. International journal of pharmaceutics. 2015 Jan 30;478(2):665-81.

[97] Wu J, He C, Bu J, Luo Y, Yang S, Ye C, Yu S, He B, Yin Y, Yang X. Betaine attenuates LPS-induced downregulation of Occludin and Claudin-1 and restores intestinal barrier function. BMC veterinary research. 2020 Dec;16(1):1-8.

[98] Lau E, Marques C, Pestana D, Santoalha M, Carvalho D, Freitas P, Calhau C. The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. Nutrition and metabolism. 2016 Dec;13(1):1-7.

[99] Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, Van der Zee DC, Brouwers HA, Verhoeven BH, van Heurn LE, Kramer BW. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Annals of surgery. 2010 Jun 1;251(6):1174-80.

[100] Sikora M, Stec A, Chrabaszcz M, Waskiel-Burnat A, Zaremba M, Olszewska M, Rudnicka L. Intestinal fatty acid binding protein, a biomarker of intestinal barrier, is associated with severity of psoriasis. Journal of clinical medicine. 2019 Jul;8(7):1021.

[101] Machado MC, Barbeiro HV, da Silva FP, de Souza HP. Circulating fatty acid binding protein as a marker of intestinal failure in septic patients. Critical Care. 2012 Dec;16(6):1-2.

[102] Ikhtaire S, Shajib MS, Reinisch W, Khan WI. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of gastroenterology. 2016 May 1;51(5):434-46.

[103] Kell MR, Barry BD, Redmond HP. Systemic inflammatory response syndrome: a new direction?. Irish journal of medical science. 2003 Mar 1;172(1):7-8.

[104] De Rosa S, Cutuli SL, Ferrer R, Antonelli M, Ronco C. Polymyxin B hemoperfusion in COVID-19 Patients with endotoxic shock: Case Series from EUPHAS II registry. Artificial Organs. 2020 Dec 30.

[105] Oostdijk EA, de Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ, Benus RF, Bernards SA, Frénay IH, Jansz AR, de Jongh BM, Kaan JA. Ecological effects of selective decontamination on resistant gramnegative bacterial colonization. American journal of respiratory and critical care medicine. 2010 Mar 1;181(5):452-7.

[106] Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. Bmj. 2016 May 23;353.

[107] Al-Banna NA, Pavlovic D, Bac VH, Utpatel K, Janke E, Rippke JN, Borowiak M, Cerny V, Spassov A, Johnston B, Issekutz TB. Acute administration of antibiotics modulates intestinal capillary perfusion and leukocyte adherence during experimental sepsis. International journal of antimicrobial agents. 2013 Jun 1;41(6):536-43.

[108] Wen ZL, Zhang LD, Liu SZ, Liu J, Chen YZ, Chen DC. Effect of broadspectrum antibiotics on bacterial translocation in burned or septic rats. Chinese medical journal. 2019 May 20;132(10):1179.

[109] Oostdijk EA, Kesecioglu J, Schultz MJ, Visser CE, De Jonge E, van Essen EH, Bernards AT, Purmer I, Brimicombe R, Bergmans D, van Tiel F. Notice of retraction and replacement: Oostdijk et al. effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA. 2014; 312 (14): 1429-1437. Jama. 2017 Apr 18;317(15):1583-4.

[110] Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut. 2016 Jul 1;65(7):1100-9.

[111] Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal antiinflammatory drug induced enteropathy. Gut. 1992 Sep 1;33(9):1204-8.

[112] Czarnetzki C, Elia N, Frossard JL, Giostra E, Spahr L, Waeber JL, Pavlovic G, Lysakowski C, Tramèr MR. Erythromycin for gastric emptying in patients undergoing general anesthesia for emergency surgery: a randomized clinical trial. JAMA surgery. 2015 Aug 1;150(8):730-7.

[113] Jia L, Chen H, Yang J, Fang X, Niu W, Zhang M, Li J, Pan X, Ren Z, Sun J, Pan LL. Combinatory antibiotic treatment protects against experimental acute pancreatitis by suppressing gut bacterial translocation to pancreas and inhibiting NLRP3 inflammasome pathway. Innate immunity. 2020 Jan;26(1):48-61.

[114] Bellot P, Francés R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver International. 2013 Jan;33(1):31-9.

[115] Hollander D, Kaunitz JD. The "Leaky Gut": Tight Junctions but Loose Associations?. Digestive diseases and sciences. 2020 May;65(5):1277.

[116] Kaliannan K, Hamarneh SR, Economopoulos KP, Alam SN,

Moaven O, Patel P, Malo NS, Ray M, Abtahi SM, Muhammad N, Raychowdhury A. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proceedings of the National Academy of Sciences. 2013 Apr 23;110(17):7003-8.

[117] Hamarneh SR, Kim BM, Kaliannan K, Morrison SA, Tantillo TJ, Tao Q, Mohamed MM, Ramirez JM, Karas A, Liu W, Hu D. Intestinal alkaline phosphatase attenuates alcohol-induced hepatosteatosis in mice. Digestive diseases and sciences. 2017 Aug;62(8):2021-34.

[118] Ghosh SS, He H, Wang J, Korzun W, Yannie PJ, Ghosh S. Intestine-specific expression of human chimeric intestinal alkaline phosphatase attenuates Western diet-induced barrier dysfunction and glucose intolerance. Physiological reports. 2018 Jul;6(14):e13790.

[119] Song D, Zong X, Zhang H, Wang T, Yi H, Luan C, Wang Y. Antimicrobial peptide Cathelicidin-BF prevents intestinal barrier dysfunction in a mouse model of endotoxemia. International immunopharmacology. 2015 Mar 1;25(1):141-7.

[120] Wang J, Ghosh SS, Ghosh S. Curcumin improves intestinal barrier function: modulation of intracellular signaling, and organization of tight junctions. American Journal of Physiology-Cell Physiology. 2017 Apr 1;312(4):C438-45.

[121] He Y, Yuan X, Zuo H, Sun Y, Feng A. Berberine exerts a protective effect on gut-vascular barrier via the modulation of the Wnt/beta-catenin signaling pathway during sepsis. Cellular Physiology and Biochemistry. 2018;49(4):1342-51.

[122] Zong Y, Zhu S, Zhang S, Zheng G, Wiley JW, Hong S. Chronic stress and intestinal permeability: Lubiprostone

*Intestinal Barrier Dysfunction, Bacterial Translocation and Inflammation: Deathly Triad… DOI: http://dx.doi.org/10.5772/intechopen.99554*

regulates glucocorticoid receptormediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human. Neurogastroenterology and Motility. 2019 Feb;31(2):e13477.

[123] Xu H, Wang Y, Jurutka PW, Wu S, Chen Y, Cao C, Chen G, Tian B, Wang S, Cheng S. 16α-Hydroxytrametenolic acid from Poria cocos improves intestinal barrier function through the glucocorticoid receptor-mediated PI3K/ Akt/NF-κB pathway. Journal of agricultural and food chemistry. 2019 Sep 13;67(39):10871-9.

[124] Deng J, Zeng L, Lai X, Li J, Liu L, Lin Q, Chen Y. Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation. Journal of Cellular and Molecular Medicine. 2018 Jan;22(1):546.

[125] Wang X, Buechler NL, Yoza BK, McCall CE, Vachharajani VT. Resveratrol attenuates microvascular inflammation in sepsis via SIRT-1-Induced modulation of adhesion molecules in ob/ob mice. Obesity. 2015 Jun;23(6):1209-17.

[126] Wang L, Cui YL, Zhang Z, Lin ZF, Chen DC. Rhubarb monomers protect intestinal mucosal barrier in sepsis via junction proteins. Chinese medical journal. 2017 May 20;130(10):1218.

[127] Liang X, Zhou M, Ge XY, Li CB, Fang SP, Tang L, Shao DH, Xu G. Efficacy of traditional Chinese medicine on sepsis: a systematic review and Meta-Analysis. International journal of clinical and experimental medicine. 2015;8(11):20024.

[128] Liu F, Liu J, Liu Y, Zhang Y, Ding X. Shen-Fu Decoction could ameliorate intestinal permeability by regulating the intestinal expression of tight junction proteins and p-VASP in septic rats. Journal of Ethnopharmacology. 2021 Mar 25;268:113562.

[129] Mack DR. Probiotics: Mixed messages. Canadian Family Physician. 2005 Nov 10;51(11):1455.

[130] Reddy VS, Patole SK, Rao S. Role of probiotics in short bowel syndrome in infants and children—a systematic review. Nutrients. 2013 Mar;5(3):679-99.

[131] Gharajalar SN, Kazemi-Darabadi S, Lajimi HV, Shahbazfar AA. The Roles of Lactobacillus Acidophilus and Pectin in Preventing Postoperative Sepsis and Intestinal Adaptation in a Rat Model of Short Bowel Syndrome. Probiotics and Antimicrobial Proteins. 2021 Mar 14:1-8.

[132] Jo SG, Noh EJ, Lee JY, Kim G, Choi JH, Lee ME, Song JH, Chang JY, Park JH. Lactobacillus curvatus WiKim38 isolated from kimchi induces IL-10 production in dendritic cells and alleviates DSS-induced colitis in mice. Journal of Microbiology. 2016 Jul;54(7):503-9.

[133] Chen L, Li H, Li J, Chen Y, Yang Y. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis. International journal of molecular medicine. 2019 Mar 1;43(3):1139-48.

[134] Shimizu K, Yamada T, Ogura H, Mohri T, Kiguchi T, Fujimi S, Asahara T, Yamada T, Ojima M, Ikeda M, Shimazu T. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial. Critical care. 2018 Dec;22(1):1-9.

[135] Ávila PR, Michels M, Vuolo F, Bilésimo R, Burger H, Milioli MV, Sonai B, Borges H, Carneiro C, Abatti M, Santana IV. Protective effects of fecal microbiota transplantation in sepsis are independent of the modulation of the intestinal flora. Nutrition. 2020 May 1;73:110727.

[136] Lamprecht G, Heininger A. Current aspects of sepsis caused by bacterial translocation. Zentralblatt fur Chirurgie. 2012 Jun 18;137(3):274-8.

[137] Bassetti M, Bandera A, Gori A. Therapeutic potential of the gut microbiota in the management of sepsis. Annual Update in Intensive Care and Emergency Medicine 2020. 2020:293-304.

[138] Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World journal of gastroenterology: WJG. 2015 Jan 7;21(1):102.

[139] Keskey R, Cone JT, DeFazio JR, Alverdy JC. The use of fecal microbiota transplant in sepsis. Translational Research. 2020 Jul 7.

[140] Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell host and microbe. 2011 Oct 20;10(4):311-23.

[141] Gargiullo L, Del Chierico F, D'Argenio P, Putignani L. Gut microbiota modulation for multidrugresistant organism decolonization: present and future perspectives. Frontiers in microbiology. 2019 Jul 25;10:1704.
